Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 01-2022 | 10-2021 | 07-2021 | 04-2021 | 01-2021 | |
| Sales | 416 | 501 | 859 | 561 | 916 |
| Cost of Goods | 182 | 172 | 602 | 246 | 363 |
| Gross Profit | 234 | 329 | 257 | 315 | 553 |
| Operating Expenses | 1,356 | 1,296 | 1,587 | 1,371 | 1,510 |
| Operating Income | -940 | -795 | -728 | -810 | -594 |
| Interest Expense | 1 | 1 | 1 | 1 | 1 |
| Other Income | 239 | 0 | -4 | 0 | 0 |
| Pre-tax Income | -702 | -796 | -733 | -811 | -595 |
| Net Income Continuous | -702 | -796 | -733 | -811 | -595 |
| Net Income | $-702 | $-796 | $-733 | $-811 | $-595 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EBITDA(a) | $-888 | $-737 | $-689 | $-767 | $-549 |